Sarah Glickman - Director at 2seventy bio, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Stock Symbol
TSVT on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Sarah Glickman since 10/7/2024

Holdings reported by Sarah Glickman for 2seventy bio, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Stock Options (Right to buy) 24.1K $94.7K $3.93 Jun 10, 2024 Direct Common Stock
Common Stock 0 $0 $4.99 May 13, 2025 Direct
Stock Options (Right to buy) 0 May 13, 2025 Direct Common Stock

Transactions reported by Sarah Glickman for 2seventy bio, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.